Prairie Education & Research Cooperative Joins MedNet Solutions' iMedNet CRO Partner Program
Minnetonka, MN – MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, and Prairie Education & Research Cooperative (PERC), an organization specializing in cardiovascular and vascular trial management, core lab, and continuing medical education services, are pleased to announce that PERC has joined the iMedNetTM CRO Partner Program. PERC will leverage iMedNet EDC, MedNet’s innovative cloud‐based eClinical technology platform, to easily and cost‐effectively build and manage their customers’ clinical research studies.
“iMedNet EDC provides an ideal electronic data capture solution that is financially feasible for PERC’s budget sensitive companies while maintaining a high level of functionality and flexibility,” stated Cynthia Deitrick, Chief Operating Officer at PERC. “PERC looks forward to future business opportunities where iMedNet can be utilized as a seamless solution for clinical trial sponsors.”
“MedNet is honored to be working with PERC-a top quality, highly‐respected clinical services organization,” noted Brian Sweeney, Vice President of Business Development at MedNet Solutions. “We’re confident that iMedNet EDC will provide the effective and reliable technology infrastructure they need for years to come.”
Please contact MedNet Solutions for more information on iMedNet EDC or the iMedNet CRO Partner Program, and PERC for additional details on their cardiovascular and vascular clinical services.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
